Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARADIGM CORP. ARDM -- Ignore unavailable to you. Want to Upgrade?

To: JMarcus who wrote (53)	1/17/2000 4:44:00 PM
From: software salesperson	Read Replies (1) \| Respond to of 255

marc, thank you for the response.yes, the recording is no longer active. let me clarify my original query: do you know whether there are more product candidates for a liquid inhaler or for a dry powder inhaler? thanks. sales

To: JMarcus who wrote (53)	1/23/2000 12:17:00 PM
From: rkrw	Read Replies (1) \| Respond to of 255

I'm not sure I agree entirely with Miss Seringer. I'd think a more complex device could raise a whole batch full of unique reliability issues that a more simplistic device wouldn't share. I'm also not sure diabetics need to such sophistication and physician monitoring. They've gotten by with needles and injection for nearly a century. Alkermes bought a drug delivery firm, AIR, that touts among other things, the simplicity of its device. So simple and cheap to mfg they're considering disposable devices for certain high cost drugs. FYI: I own shares of both ARDM and ALKS.